Paula Camilo Contaiffer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Paula Camilo Contaiffer has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alba Otoni
Federal University of São João del-Rei image/svg+xml
1 shared publication - Ana Luiza Corrêa Silva
Universidade Federal de São João del-Rei
1 shared publication - André Oliveira Baldoni
Universidade Federal de São João del-Rei, Brazil
1 shared publication - Flávio Augusto de Morais
Ambulatório Municipal de Nefrologia - PMDivinópolis
1 shared publication - João Pedro Vasconcelos Paolinelli
Federal University of São João del-Rei , Divinópolis, R. Sebastião Gonçalves Coelho, 400 - Chanadour, Divinópolis, MG 35501-296
1 shared publication - Karla Amaral Nogueira Quadros
Universidade do Estado de Minas Gerais
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (1)
Potenciais interações medicamentosas graves em pacientes com doença renal crônica não dialítica: uma frequência preocupante
Objective: to evaluate potential severe and moderate drug interactions in patients with chronic kidney disease (CKD) not on dialysis and using polypharmacy. Methodology: cross-sectional study carried out in a city in the center-west of Minas Gerais/Brazil. The population consisted of patients with non-dialysis kidney disease treated at the municipal nephrology clinic. Descriptive analysis was used to characterize the sociodemographic, clinical, and laboratory profile of the population. Bivariate logistic regression analysis was applied to determine factors associated with potential drug interactions. Variables with p-value < 0.20 were taken to the multivariate model. Results: Of the total of 75 participants, most were female, elderly and white. Among them, 60% (45/75) were in stage 3A and 3B of kidney disease. No significant association was found between the use of polypharmacy and Estimated Glomerular Filtration Rate (p Conclusions: high rates of moderate drug interactions were found, in addition to the presence of severe interactions. The association of multiple drugs in pharmacotherapy, especially for elderly patients with kidney disease, is often unavoidable and, therefore, deserves special attention not only from prescribing professionals but also from the entire team in order to safeguard the safety of these patients, avoiding events adverse events related to MIs.
- 1 January 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (1)
Open AccessPotenciais interações medicamentosas graves em pacientes com doença renal crônica não dialítica: uma frequência preocupante
Objective: to evaluate potential severe and moderate drug interactions in patients with chronic kidney disease (CKD) not on dialysis and using polypharmacy. Methodology: cross-sectional study carried out in a city in the center-west of Minas Gerais/Brazil. The population consisted of patients with non-dialysis kidney disease treated at the municipal nephrology clinic. Descriptive analysis was used to characterize the sociodemographic, clinical, and laboratory profile of the population. Bivariate logistic regression analysis was applied to determine factors associated with potential drug interactions. Variables with p-value < 0.20 were taken to the multivariate model. Results: Of the total of 75 participants, most were female, elderly and white. Among them, 60% (45/75) were in stage 3A and 3B of kidney disease. No significant association was found between the use of polypharmacy and Estimated Glomerular Filtration Rate (p Conclusions: high rates of moderate drug interactions were found, in addition to the presence of severe interactions. The association of multiple drugs in pharmacotherapy, especially for elderly patients with kidney disease, is often unavoidable and, therefore, deserves special attention not only from prescribing professionals but also from the entire team in order to safeguard the safety of these patients, avoiding events adverse events related to MIs.